Special Issues

Livers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process. The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue policies and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.

Search by Title/Keyword
 
Order results
Display
Results per page
Recent Advances in Acetaminophen Hepatotoxicity submission deadline 31 May 2025 | 10 articles | Viewed by 39332 | Submission Open
Keywords: mitochondria; oxidant stress and peroxynitrite; adaptive responses (autophagy; mitophagy); ER stress; sterile inflammation; macrophages and neutrophils; regeneration; N-acetylcysteine; fomepizole
Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment
edited by and Tilman Sauerbruch
submission deadline 31 May 2025 | 8 articles | Viewed by 11990 | Submission Open
Keywords: fibrosis; hepatic stellate cells; portal hypertension; extracellular matrix; cytokines; chemokines; biomarkers; NASH; NAFLD; cirrhosis; hepatocellular carcinoma; therapy; animal models; imaging of hepatic fibrosis; biomarkers of hepatic fibrosis
Recent Advances in the Detection and Pathophysiology of Steatotic, Alcoholic and Drug-Induced Liver Diseases
edited by , , Anabel Martinez Lyons and
submission deadline 10 Jun 2025 | 1 articles | Viewed by 1467 | Submission Open
Keywords: acetaminophen-induced hepatotoxicity; alcoholic liver disease (ALD); biomarkers and molecular targeting for CLDs; chronic liver disease (CLD); drug-induced liver injury (DILI); extracellular microenvironment and cell-cell communication in CLDs; genetic variants influencing MASLD-MASH; hepatic inflammation; in vitro and in vivo CLD modelling; lipotoxicity; metabolic dysfunction-associated steatohepatitis (MASH); metabolic dysfunction-associated steatotic liver disease (MASLD); multiomics and systems biology; new tools and technologies in the study of CLDs; novel therapeutic strategies for CLDs and precision medicine
Liver Macrophage Diversity and Functions in MASLD and ALD
edited by Adeline Bertola
submission deadline 15 Sep 2025 | Viewed by 154 | Submission Open
Keywords: metabolic dysfunction-associated steatotic liver disease (MASLD); alcohol-related liver disease (ALD); steatosis; steatohepatitis; fibrosis; Kupffer cells; monocyte-derived macrophages
The Surveillance, Prevention, and Treatment of Viral Hepatitis: Looking Forward to Global Elimination
edited by
submission deadline 31 Oct 2025 | Viewed by 46 | Submission Open
Keywords: viral hepatitis surveillance systems; preventive measures (preventive strategies; vaccination programs; awareness campaigns; harm reduction initiatives aimed at reducing transmission rates; and targeted prevention efforts for at-risk populations); diagnostic innovations: advances in diagnostic technologies and new methods for the early detection of hepatitis viruses; antiviral therapies for hepatitis B; C; and D (existing treatments and the emergence of new therapeutic options and strategies); public health policies in addressing the viral hepatitis epidemic; challenges and barriers faced in the surveillance; prevention; and treatment of viral hepatitis (healthcare access disparities; stigma; and the need for integrated healthcare approaches); collaborative efforts among stakeholders; including governments; healthcare providers; and community organizations; in enhancing hepatitis control; digital health solutions that aim to improve awareness; education; and access to care for hepatitis patients
Back to TopTop